HomeZYUS • CVE
add
ZYUS Life Sciences Corp
Previous close
$0.74
Year range
$0.55 - $1.11
Market cap
56.57M CAD
Avg Volume
18.54K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 126.00K | 29.90% |
Operating expense | 3.14M | -40.65% |
Net income | -21.74M | 11.22% |
Net profit margin | -17.25K | 31.66% |
Earnings per share | -0.05 | 16.85% |
EBITDA | -3.96M | 43.46% |
Effective tax rate | 8.57% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.90M | -67.50% |
Total assets | 14.67M | -64.75% |
Total liabilities | 20.02M | 8.12% |
Total equity | -5.34M | — |
Shares outstanding | 74.36M | — |
Price to book | -10.57 | — |
Return on assets | -44.10% | — |
Return on capital | -72.38% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -21.74M | 11.22% |
Cash from operations | -5.30M | -92.59% |
Cash from investing | 1.87M | 831.64% |
Cash from financing | 4.98M | 1,591.92% |
Net change in cash | 1.56M | 146.56% |
Free cash flow | -1.68M | -218.01% |
About
Founded
2018
Headquarters
Website
Employees
2
